11/12/2024
10:26 AM | Haemonetics (Subject)
Lingamneni Anila (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
9:41 AM | Haemonetics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/07/2024
5:03 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
5:11 AM | Haemonetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
3:17 PM | Galvin Roy (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:18 PM | Haemonetics (Issuer)
Miller Laurie A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:20 PM | Haemonetics (Issuer)
Simon, Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/08/2024
5:04 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
5:05 AM | Haemonetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2024
3:23 PM | Haemonetics (Filer)
| Form 8-K/A | |
07/29/2024
4:03 PM | Haemonetics (Issuer)
Strong Stewart W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
3:29 PM | COYLE MICHAEL J (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
3:30 PM | Bryant Diane M (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
3:32 PM | ABERNATHY ROBERT E (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
3:34 PM | Haemonetics (Issuer)
Strong Stewart W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
3:21 PM | Haemonetics (Issuer)
Zane Ellen M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
8:47 AM | Haemonetics (Subject)
Strong Stewart W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024
3:10 PM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
3:27 PM | Haemonetics (Issuer)
Lingamneni Anila (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
3:25 PM | Haemonetics (Subject)
Lingamneni Anila (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2024
3:42 PM | Haemonetics (Subject)
Lingamneni Anila (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024
5:30 AM | Haemonetics (Filer)
| Form DEFA14A | |
06/07/2024
5:31 AM | Haemonetics (Filer)
| Form ARS | |
06/07/2024
5:26 AM | Haemonetics (Filer)
| Form DEF 14A | |
05/29/2024
4:42 PM | Haemonetics (Issuer)
Llorens Josep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:44 PM | Haemonetics (Issuer)
Lingamneni Anila (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:27 PM | Haemonetics (Issuer)
Strong Stewart W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:31 PM | Haemonetics (Issuer)
Simon, Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:35 PM | Haemonetics (Issuer)
Miller Laurie A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:38 PM | Basil Michelle L (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:06 PM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
10:06 AM | Basil Michelle L (Reporting)
Haemonetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
9:24 AM | Haemonetics (Subject)
Strong Stewart W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024
5:03 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2024
4:49 PM | Galvin Roy (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:52 PM | Haemonetics (Issuer)
Llorens Josep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:55 PM | Haemonetics (Issuer)
Lingamneni Anila (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:58 PM | Haemonetics (Issuer)
Miller Laurie A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:01 PM | Haemonetics (Issuer)
Strong Stewart W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:05 PM | Haemonetics (Issuer)
Maunsell Farris Maryanne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:41 PM | DArecca James (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad) The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget!
We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] |
05/21/2024
4:46 PM | Basil Michelle L (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:38 PM | Haemonetics (Issuer)
Simon, Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
10:13 AM | Basil Michelle L (Reporting)
Haemonetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024
10:24 AM | Haemonetics (Subject)
Strong Stewart W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024
9:45 AM | Haemonetics (Subject)
Llorens Josep (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024
5:16 AM | Haemonetics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
05/17/2024
4:11 PM | Haemonetics (Issuer)
Strong Stewart W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
3:52 PM | DArecca James (Reporting)
Haemonetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
3:55 PM | Haemonetics (Issuer)
Llorens Josep (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
11:15 AM | Basil Michelle L (Reporting)
Haemonetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024
9:07 AM | Haemonetics (Subject)
Llorens Josep (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
11:57 AM | Haemonetics (Subject)
Llorens Josep (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
11:12 AM | Basil Michelle L (Reporting)
Haemonetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
11:15 AM | Haemonetics (Subject)
Strong Stewart W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
5:04 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
3:21 PM | Haemonetics (Issuer)
Lingamneni Anila (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
1:08 PM | Haemonetics (Subject)
Lingamneni Anila (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
3:18 PM | Haemonetics (Issuer)
Lingamneni Anila (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
7:01 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
3:44 PM | Haemonetics (Issuer)
Simon, Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
5:10 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
2:28 PM | Haemonetics (Subject)
Neuberger Berman Group LLC (Filed by)
| Form SC 13G/A | |
02/09/2024
4:49 PM | Capital Research Global Investors (Filed by)
Haemonetics (Subject)
| Form SC 13G/A | |
02/08/2024
9:21 AM | Haemonetics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
02/08/2024
5:05 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/08/2024
5:06 AM | Haemonetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
12/12/2023
5:09 AM | Haemonetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
